Clinical Trial 19130

Cancer Type: Gastrointestinal Tumor
Interventions:177Lu-DOTA0-Ty3-Octreotate (Lutathera); Lutathera

Study Type: Treatment
Phase of Study: NA
Investigators:

  • Ghassan El-Haddad

Overview

Study Title

Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients with Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive under Somatostatin Analogue Therapy.

Summary

Objective